<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001798929</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001359931</issuerCik>
      <issuerName>Protara Therapeutics, Inc.</issuerName>
      <secFileNumber>001-36694</secFileNumber>
      <issuerAddress>
        <com:street1>345 PARK AVENUE SOUTH</com:street1>
        <com:street2>3RD FLOOR</com:street2>
        <com:city>NEW YORK</com:city>
        <com:stateOrCountry>NY</com:stateOrCountry>
        <com:zipCode>10010</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>646-844-0337</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Zummo Jacqueline</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>COMMON</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>THE CHARLES SCHWAB CORPORATION</name>
        <address>
          <com:street1>3000 Schwab Way</com:street1>
          <com:city>Westlake</com:city>
          <com:stateOrCountry>TX</com:stateOrCountry>
          <com:zipCode>76262</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>21224</noOfUnitsSold>
      <aggregateMarketValue>96569.00</aggregateMarketValue>
      <noOfUnitsOutstanding>36767465</noOfUnitsOutstanding>
      <approxSaleDate>03/26/2025</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>COMMON</securitiesClassTitle>
      <acquiredDate>01/03/2023</acquiredDate>
      <natureOfAcquisitionTransaction>RSU GRANTS ACQUIRED BETWEEN: 1/3/23 - 1/19/24</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>ISSUER</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>21224</amountOfSecuritiesAcquired>
      <paymentDate>01/03/2023</paymentDate>
      <natureOfPayment>NA</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>03/26/2025</noticeDate>
      <planAdoptionDates>
        <planAdoptionDate>12/23/2024</planAdoptionDate>
      </planAdoptionDates>
      <signature>JACQUELINE A ZUMMO</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
[{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 2892}]
144
0001798929
XXXXXXXX
LIVE
0001359931
Protara Therapeutics, Inc.
001-36694
345 PARK AVENUE SOUTH
3RD FLOOR
NEW YORK
NY
10010
646-844-0337
Zummo Jacqueline
Officer
COMMON
THE CHARLES SCHWAB CORPORATION
3000 Schwab Way
Westlake
TX
76262
21224
96569.00
36767465
03/26/2025
NASDAQ
COMMON
01/03/2023
RSU GRANTS ACQUIRED BETWEEN: 1/3/23 - 1/19/24
ISSUER
N
21224
01/03/2023
NA
Y
03/26/2025
12/23/2024
JACQUELINE A ZUMMO